The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

Shares of Merck KGaA surged after the company confirmed its outlook for fiscal year 2024 and revisions to its mid-term sales ...

Merck KGaA said its doors are open for more M&A, particularly for its manufacturing business, as the company tempers sales ...

German stocks traded higher on Thursday as investors digested a slew of earnings and awaited an interest rate cut by the European ...

Germany stocks were higher after the close on Thursday, as gains in the Pharmaceuticals & Healthcare, Industrials and ...

Germany equities were higher at the close on Thursday, as gains in the Pharmaceuticals & Healthcare, Industrials and ...

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in ...

Alopecia industry is projected to witness a CAGR of 8.1% during the period 2024-2032. This growth can be attributed to the ...

European stocks traded higher on Thursday as investors digested a slew of earnings and awaited the European Central Bank's ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing ...